GRP
ADPT icon

Global Retirement Partners’s Adaptive Biotechnologies ADPT Stock Holding History

Global Retirement Partners’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$568 Sell
35
-2
-5% -$33 ﹤0.01% 3978
2025
Q3 		$554 Hold
37
– – ﹤0.01% 3628
2025
Q2 		$431 Buy
+37
New +$336 ﹤0.01% 3587
2024
Q4 		$66 Hold
11
– – ﹤0.01% 3568
2024
Q3 		$56 Hold
11
– – ﹤0.01% 3436
2024
Q2 		$40 Hold
11
– – ﹤0.01% 3496
2024
Q1 		$35 Hold
11
– – ﹤0.01% 3340
2023
Q4 		$47 Sell
11
-41
-79% -$187 ﹤0.01% 3301
2023
Q3 		$250 Hold
52
– – ﹤0.01% 3092
2023
Q2 		$349 Hold
52
– – ﹤0.01% 3026
2023
Q1 		$390 Hold
52
– – ﹤0.01% 2976
2022
Q4 		$397 Hold
52
– – ﹤0.01% 2806
2022
Q3 		$0 Sell
52
-29
-36% -$273 ﹤0.01% 2664
2022
Q2 		$1K Sell
81
-20
-20% -$176 ﹤0.01% 2327
2022
Q1 		$1K Buy
+101
New +$1.59K ﹤0.01% 2294

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Global Retirement Partners's ADPT Position: Q4 2025 in Review

Global Retirement Partners reduced its Adaptive Biotechnologies (ADPT) stake by 5.4% in Q4 2025, selling an estimated $33 and leaving 35 shares worth $568. The position accounts for ﹤0.01% of the portfolio, ranked #3978.

Global Retirement Partners first reported a position in ADPT in Q1 2022 and has held it in 15 quarters since. The position peaked at $1K in Q2 2022. 283 funds tracked by Wall St. Rank hold ADPT as of Q4 2025.

  • Global Retirement Partners held 35 shares of Adaptive Biotechnologies worth $568 as of Q4 2025.
  • Global Retirement Partners sold 2 Adaptive Biotechnologies shares in Q4 2025, an estimated $33.
  • Adaptive Biotechnologies made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3978 holding.
  • Global Retirement Partners first reported a position in Adaptive Biotechnologies in Q1 2022 and has held it in 15 quarters since.
  • Global Retirement Partners's Adaptive Biotechnologies position peaked at $1K in Q2 2022.
  • 283 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.